A young kiwi patient will be one of the first to be treated with a radical new treatment for a rare disease.
The drug will be used to target muscle cells and silence a gene which causes Facioscapulohumeral Muscular Dystrophy.
Neurologist and trial lead Richard Roxburgh says the method is promising.
LISTEN ABOVE

Mike's Minute: Again, get housing out of fast-track
02:12

Mark the Week: Is this a new low for Trump?
02:30

Mike's Minute: It hasn't been a good week for Labour
02:21